{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Lexington",
      "address_1": "300 Shire Way",
      "reason_for_recall": "Defective Delivery System: potential risk of rubber stopper particles clogging the needle and leading to underdosing",
      "address_2": "",
      "product_quantity": "8,003",
      "code_info": "06828752, exp 12/31/2019   07110118, exp 4/30/2021   07164107, exp 12/31/2019   07200436, 07301074, exp 4/30/2021   07482212, 07630715, exp 6/30/2021   07769460, exp 4/30/2021",
      "center_classification_date": "20191001",
      "distribution_pattern": "Product was distributed throughout the United States.",
      "state": "MA",
      "product_description": "Natpara (parathyroid hormone) for Injection, 100 mcg, 2 pack medication cartridges, Rx only, For subcutaneous use only, Manufactured for: Shire-NPS Pharmaceuticals, Inc., Lexington, MA  68875-0205-02",
      "report_date": "20191002",
      "classification": "Class I",
      "openfda": {},
      "recalling_firm": "Shire Human Genetic Therapies, Inc.",
      "recall_number": "D-0038-2020",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "83792",
      "termination_date": "20210323",
      "more_code_info": "",
      "recall_initiation_date": "20190912",
      "postal_code": "02421-2101",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}